Processa Pharmaceuticals, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Processa Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Processa Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -151 %, a 35.2% increase year-over-year.
  • Processa Pharmaceuticals, Inc. annual Return On Equity for 2023 was -141 %, a 12.3% increase from 2022.
  • Processa Pharmaceuticals, Inc. annual Return On Equity for 2022 was -161 %, a 300% decline from 2021.
  • Processa Pharmaceuticals, Inc. annual Return On Equity for 2021 was -40.4 %, a 70.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -141 +19.8 +12.3% Jan 1, 2023 Dec 31, 2023
2022 -161 -121 -300% Jan 1, 2022 Dec 31, 2022
2021 -40.4 +96 +70.4% Jan 1, 2021 Dec 31, 2021
2020 -136 -97.2 -248% Jan 1, 2020 Dec 31, 2020
2019 -39.2 -0.33 -0.85% Jan 1, 2019 Dec 31, 2019
2018 -38.8 -201 -124% Jan 1, 2018 Dec 31, 2018
2017 162 +74.7 +85.8% Jan 1, 2017 Dec 31, 2017
2016 87.1 -491 -84.9% Jan 1, 2016 Dec 31, 2016
2015 578 +1.24K Jan 1, 2015 Dec 31, 2015
2014 -660 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.